Mind Over Matter for Black and African American Women: A Single Arm Trial Examining Feasibility and Acceptability of a Supportive Intervention
NCT ID: NCT06168825
Last Updated: 2025-02-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
40 participants
OBSERVATIONAL
2024-01-17
2024-06-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
• Whether the MOM Intervention is feasible and acceptable among Black and African American women.
We would also like to find out if:
* The MOM Intervention decreases anxiety, depression and physical symptom severity for Black and African American women.
* The MOM Intervention is culturally and linguistically appropriate, and identify barriers, strengths, and areas of improvement.
Participants will:
* Attend a Pre-Program Orientation
* Attend 5 weekly MOM Sessions
* Complete 2 questionnaires (one will be given before the first MOM Session begins, and the other will be given after the last MOM Session)
Participants also have the choice to attend an optional Focus Group, which will be offered after the last MOM Session.
Please note, this entire Intervention will be offered online. There will be no in-person sessions or visits.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pilot Trial of Spiritual Care Interventions for Patients With Cancer
NCT06811376
Faith-Based African American Cancer Survivorship Storytelling
NCT03082612
Developing a Culturally Relevant Supportive Care Program for Black Patients Dealing With Advanced Cancer
NCT05763797
Mindfulness-Based Stress Reduction to Improve Well-being in Black Adult Cancer Survivors, Community Faith-based Mindfulness Ministry
NCT06767475
Yoga to Improve Disparities in Cancer Survivorship
NCT07165600
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Inova Life with Cancer® has developed Mind Over Matter (MOM), a group psychosocial program designed to teach emotional coping skills to anyone affected by cancer. MOM consists of five, 1.5-hour sessions. The foundational theories of MOM are Cognitive Behavioral Therapy (CBT), Acceptance \& Commitment Therapy (ACT), and the physiology of the stress response. Each session introduces a core cognitive concept and a different relaxation exercise. These sessions are structured and educational, with a focus on building skills, and are not a therapy or a support group. At the end of each session, participants are given exercises to practice the core cognitive concept and the relaxation at home. Participants are also offered optional reading to support the core cognitive concept. Practice outside of the class is vital. Thus, it is important to allow enough time to process and review the home practice exercises each week - this is the core of the program.
A retrospective secondary data analysis of the MOM intervention found a significant decrease in anxiety, depression, physical symptom severity, and physical symptom interference from pre- to post-test.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Black and African American Women diagnosed with Cancer
Participants who have completed primary treatment (completed chemotherapy and/or radiation and/or surgery) are eligible to participate in the study
Mind Over Matter (MOM)
Each participant's involvement in the study will include:
* Attending a Pre-Program Orientation which will be held a week before the first MOM Session.
* Completing 5 weekly sessions of MOM
* Completing 2 surveys; one will be given before the start of the intervention (a pre-test) and the other will be given after the last MOM Session (a post-test)
Participants will also have the option to participate in an optional Focus Group session which will occur a week after the last MOM Session ends
Participants will spend about 6 weeks in this study. If they decide to participate in the optional session, they will spend about 7 weeks in this study.
Please note, this entire Intervention will be offered online. There will be no in-person sessions or visits.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mind Over Matter (MOM)
Each participant's involvement in the study will include:
* Attending a Pre-Program Orientation which will be held a week before the first MOM Session.
* Completing 5 weekly sessions of MOM
* Completing 2 surveys; one will be given before the start of the intervention (a pre-test) and the other will be given after the last MOM Session (a post-test)
Participants will also have the option to participate in an optional Focus Group session which will occur a week after the last MOM Session ends
Participants will spend about 6 weeks in this study. If they decide to participate in the optional session, they will spend about 7 weeks in this study.
Please note, this entire Intervention will be offered online. There will be no in-person sessions or visits.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Self-identify as female or a woman
* Having received a diagnosis and treatment for any type of cancer
* Having completed primary treatment (completed chemotherapy and/or radiation and/or surgery)
* ≥18 years of age
* Able to understand and provide valid informed consent prior to any study procedure
* Access to the internet and email
* Being able to speak and understand written and spoken English
Exclusion Criteria
* Does not Self-identify as a female or a woman
* Does not have a diagnosis of cancer
* Has not completed primary treatment
* Under the age of 18
* Not able to understand and provide valid informed consent
* Does not have access to the internet or email
* Not being able to speak, read and understand English
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Howard University
OTHER
University of Louisville
OTHER
University of Houston
OTHER
VCU Massey Cancer Center
UNKNOWN
Tigerlily Foundation
UNKNOWN
Inova Health Care Services
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michelle Ferretti, MSW, LCSW, OSW-C
Role: PRINCIPAL_INVESTIGATOR
Inova Health Care Services
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Howard University Cancer Center
Washington D.C., District of Columbia, United States
Inova Life With Cancer
Fairfax, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ferretti M, Lowery Walker K, Bires J, BrintzenhofeSzoc K. Building coping skills to relieve distress and physical symptoms: Findings from a quality improvement project of a five-week group psychoeducational program for cancer patients. J Psychosoc Oncol. 2024;42(2):256-270. doi: 10.1080/07347332.2023.2238263. Epub 2023 Jul 24.
Related Links
Access external resources that provide additional context or updates about the study.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
U23-06-5102
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.